Retatrutide
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
Same Day Dispatch
A dual GIP and GLP-1 receptor agonist studied in metabolic and glucoregulatory research.
International cards accepted ยท Checkout in AUD
Secure checkout ยท AU: Free standard over $149 ยท Free express over $199 ยท Research use only
๐ฆ Dispatched within 24hrs ยท Ships from Sydney & Melbourne
International cards accepted ยท Checkout in AUD
Tirzepatide is a synthetic dual-incretin peptide that simultaneously activates the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In laboratory research it is investigated for its effects on insulin signalling, glucose homeostasis and energy-balance pathways in experimental models.
In controlled laboratory environments, Tirzepatide is studied for:
Individual researcher experiences. For laboratory and research use only.
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
Same Day Dispatch
Join the Pepreta research list for new product drops, third-party COA releases and members-only pricing. No spam โ unsubscribe anytime.